Max Robotics — Global Service Robot Directory + US Certification

About

Francesca Magnoni is a leading surgical oncologist whose work is redefining the landscape of breast cancer surgery, with a primary focus on robotic-assisted techniques. Her major contributions center on the rigorous clinical evaluation of robotic mastectomy, directly comparing its outcomes to traditional open surgery. Her landmark 2021 randomized trial, cited over 100 times, provided critical, high-level evidence on the surgical, oncologic, and quality-of-life outcomes of robotic nipple-sparing mastectomy, demonstrating its feasibility and potential advantages for carefully selected patients. This work, alongside her comprehensive 2019 update on the field (cited 88 times), has established her as a key authority in advancing minimally invasive options for breast cancer treatment and risk reduction in women with BRCA mutations. By systematically proving the safety and efficacy of these novel approaches, Magnoni is helping to shape a future where surgical precision and improved patient recovery are paramount. Her research not only informs clinical practice but also empowers patients with more choices, solidifying her reputation as a pioneer in the evolution of breast surgical oncology.